Prosight Management, LP Blueprint Medicines Corp Transaction History
Prosight Management, LP
- $337 Million
- Q4 2024
A detailed history of Prosight Management, LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Prosight Management, LP holds 67,000 shares of BPMC stock, worth $6.32 Million. This represents 1.74% of its overall portfolio holdings.
Number of Shares
67,000
Previous 47,100
42.25%
Holding current value
$6.32 Million
Previous $4.35 Million
34.2%
% of portfolio
1.74%
Previous 1.17%
Shares
2 transactions
Others Institutions Holding BPMC
# of Institutions
380Shares Held
65.9MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$639 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$627 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$536 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA4.28MShares$404 Million0.07% of portfolio
-
State Street Corp Boston, MA2.5MShares$236 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.63B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...